O'DONNELL ENTERPRISES LIMITED

Company number 14687610 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

O'DONNELL ENTERPRISES LIMITED - Analysis Report

Company Number: 14687610

Analysis Date: 2025-07-29 14:37 UTC

Financial Health Assessment for O'DONNELL ENTERPRISES LIMITED


1. Financial Health Score: B

Explanation:
The company demonstrates sound early-stage financial health with positive net current assets and a healthy cash position. Given it is a newly incorporated business (less than 1 year old), this score reflects a stable foundation but limited operating history. The company’s financial "vital signs" are strong, but the absence of turnover and profit/loss data restricts a higher grade.


2. Key Vital Signs

Metric Value (£) Interpretation
Cash at Bank 58,765 Healthy cash flow indicating good liquidity
Current Assets 71,923 Adequate short-term resources
Current Liabilities 35,827 Manageable short-term obligations
Net Current Assets 36,096 Positive working capital, a good liquidity buffer
Shareholders’ Funds 36,096 Equity base is positive, indicating solvency
Share Capital 100 Minimal paid-up capital typical for new companies
Employees 2 Small operational scale, aligning with micro/small company profile
Accounting Period <1 year Limited financial history, no income statement filed

Interpretation:

  • Healthy Cash Flow: The company holds a strong cash balance (£58,765) relative to current liabilities (£35,827), which is akin to a healthy pulse suggesting the company can cover short-term debts comfortably.
  • Positive Working Capital: Net current assets of £36,096 indicate the company has resources left after settling short-term obligations — a key sign of liquidity strength.
  • Equity Position: Shareholders’ funds equal net assets, reflecting no long-term debt, which is a positive "heartbeat" for financial stability.
  • Limited Financial History: The absence of reported turnover or profit/loss information is a "blind spot" analogous to missing diagnostic data. It limits insight into operational efficiency or profitability.

3. Diagnosis

O'DONNELL ENTERPRISES LIMITED is in the embryonic stage of its business lifecycle, with financials reflecting a solid capital base and liquidity. The company’s balance sheet shows no signs of distress: no debts beyond short-term creditors, positive net current assets, and a healthy cash position. The small number of employees and the nature of the SIC code (other software publishing) suggest a service-oriented model with potentially low fixed asset intensity.

However, the lack of detailed income statement data (turnover, profit, or loss) is a symptom that prevents a full assessment of operational performance. This absence could be due to the company’s short trading period or the small companies exemption from filing the profit and loss account.

At this stage, the "vital signs" show a stable financial condition with no red flags such as over-indebtedness or negative equity. The company's financial health resembles a patient who is stable but early in their treatment, requiring monitoring over time to assess growth and profitability.


4. Recommendations

  • Monitor Cash Flow Closely: Maintain the healthy liquidity by tracking receivables and payables carefully to avoid cash flow "arrhythmias."
  • Develop Income Reporting: As the company matures, ensure comprehensive income statement reporting to provide visibility into profitability and operational efficiency. This is critical for early diagnosis of potential "symptoms" like declining margins or rising costs.
  • Manage Creditors: Review the composition of creditors (£35,827), especially other creditors (£23,054), to understand payment terms and avoid liquidity stress.
  • Plan for Growth: With a solid financial foundation, focus on strategic initiatives to increase turnover and build retained earnings, which will strengthen the equity "immune system."
  • Financial Forecasting: Prepare cash flow and profit forecasts to anticipate capital needs and operational challenges, akin to preventive health check-ups.
  • Governance and Compliance: Ensure timely filing of accounts and confirmation statements to avoid penalties and maintain regulatory "fitness."
  • Consider Capital Injection: Given the minimal share capital, consider whether additional equity investment is needed to support expansion plans.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.